Latest Breaking News On - Immunome inc - Page 1 : vimarsana.com

Evaluating Immunome: Insights From 4 Financial Analysts - Immunome (NASDAQ:IMNM)

Evaluating Immunome: Insights From 4 Financial Analysts - Immunome (NASDAQ:IMNM)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Health-care
Immunome-inc
Analyst-ratings
Capitalization-analysis

Keros Therapeutics Appoints Jean-Jacques Bienaimé To Its Board Of Directors

Keros Therapeutics Appoints Jean-Jacques Bienaimé To Its Board Of Directors
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Paris
France-general
France
Jasbir-seehra
Jean-jacques-bienaime
Poulenc-rorer-pharmaceuticals
Genentech-inc
Biomarin-pharmaceutical-inc
Genencor-inc
Keros-therapeutics-inc
Company-nasdaq
Incyte-corporation

Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying - Astrotech (NASDAQ:ASTC)

United-states
American
Danh-wilks
Matthew-wilks
Raymond-james
Frankm-svoboda
Clayb-siegall
Wilma-burdis
Thomas-wiley-wilkinson
Lance-turner
Profrac-holding
Gl-co

Immunome Announces Completion of Purchase of Assets from Atreca

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of antibodies and related...

Clay-siegall
Jack-higgins
Atreca-inc
Immunome-inc
Twitter
Nasdaq
Linkedin
Chief-scientific
Chief-executive-officer
Exchange-act
Private-securities-litigation-reform-act
Annual-report

Immunome Announces Promotion of Max Rosett to Chief Financial Officer

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer,...

Boston
Massachusetts
United-states
Clay-siegall
Yale-university
Nasdaq
Boston-consulting-group
Twitter
Immunome-inc
Linkedin
Securities-exchange
Google

Immunome (NASDAQ:IMNM) Stock Price Down 4%

Immunome (NASDAQ:IMNM) Stock Price Down 4%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Jpmorgan-chase-co
Nasdaq
Immunome-company-profile
Janus-henderson-group
Pricet-rowe-associates-inc
Vanguard-group-inc
Redmile-group
Immunome-inc
Get-free-report
Trading-down
Henderson-group

Immunome (NASDAQ:IMNM) Earns "Outperform" Rating from Wedbush

Immunome (NASDAQ:IMNM) Earns "Outperform" Rating from Wedbush
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Jpmorgan-chase-co
Acadian-asset-management
Jump-financial
Nasdaq
Sei-investments-co
Immunome-inc
Entrypoint-capital
Dorsey-wright-associates
Free-report
Get-free-report
Point-capital

Immunome, Inc. Q1 Loss Increases, Misses Estimates

Immunome, Inc. Q1 Loss Increases, Misses Estimates
rttnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rttnews.com Daily Mail and Mail on Sunday newspapers.

Immunome-inc
Thomson-reuters

Immunome to Present at 2024 Bank of America Healthcare Conference

Immunome to Present at 2024 Bank of America Healthcare Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Clay-siegall
Immunome-inc
Twitter
Linkedin
Nasdaq
America-healthcare
Chief-executive-officer
America-healthcare-conference
Investor-relations

JPMorgan Chase & Co. Initiates Coverage on Immunome (NASDAQ:IMNM)

JPMorgan Chase & Co. assumed coverage on shares of Immunome (NASDAQ:IMNM – Free Report) in a research note published on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $24.00 price objective on the stock. IMNM has been the subject of several other reports. Guggenheim initiated coverage on Immunome in a report on […]

Leerink-partnrs
Td-asset-management-inc
Immunome-company-profile
Jpmorgan-chase-co
Immunome-inc
Cerity-partners
Free-report
Get-free-report
Partners-management
Management-inc
Immunome-daily
Simmunome